Navigation Links
Abviva Details Patent Information for its Breast Cancer Risk Assessment Technology
Date:5/21/2010

commercialize the Mammastatin Serum Assay as a reference test through its wholly owned subsidiary laboratory under CLIA certification.  

Statements in this press release that are not strictly historical facts are "forward-looking" statements (identified by the words "believe", "estimate", "project", "expect" or similar expressions) within the meaning of the Private Securities Litigation Reform Act of 1995. These statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company's products and services in the marketplace, competitive factors, changes in the regulatory environment, and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission. The statements in this press release are made as of today, based upon information currently known to management, and the Company does not undertake any obligation to publicly update or revise any forward-looking statements.

www.abviva.com


'/>"/>
SOURCE Abviva, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Abviva Announces Further Patent Issuance for Technology Used in Breast Cancer Diagnostics and Therapeutics
2. Details Issued Today on $1 Billion in Biotech Tax Credits and Grants
3. Oncolytics Biotech(R) Inc. Announces Details of 2010 Annual Shareholder Meeting
4. Kendle Announces Details Regarding Fourth Quarter and Full-Year 2009 Earnings Conference Call and Webcast
5. Pulmo BioTech Inc. Announces Cash Details of its Previously Announced Letter of Intent Intended to Bring its Pulmonary Vascular Diagnostic Product Candidate PulmoBind(TM) to the European Market
6. Cequent to Provide Details at BIOCOM About Planned Launch of its Clinical Program - 3 p.m., Tuesday, October 27
7. Oncolytics Biotech(R) Inc. Announces Details of 2009 Annual Shareholder Meeting
8. CryoLife Announces Release Date and Teleconference Call Details for 2009 First Quarter Financial Results
9. White Paper Details How DNA Sequencing Services Can Prevent Cleanroom Shutdowns at Medical Device and Pharmaceutical Manufacturers
10. In Analyst Interview, Cord Blood America Provides Details of Special Shareholder Meeting
11. Shire plc: Change to Directors Details
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... 22, 2013 Cambridge Semantics was ... week’s “Data Demonstration Day” on Capitol Hill, hosted by The ... Google, Microsoft and others to showcase how innovative data management ... and Transparency Act (DATA Act). , Originally introduced in 2011 ... and Sen. Mark Warner (D-VA ), the ...
(Date:5/22/2013)... NEW YORK , May 22, 2013 /PRNewswire/ ... pioneering the development of disease modifying therapeutics for ... today the completion of its Series B financing, ... shares and warrants that would represent approximately $2.8M ... investors and new investors supported the raise. ...
(Date:5/22/2013)... May 22, 2013  Superior Controls, Inc. has ... by Business NH Magazine.  For the past 22 ... that distinguish themselves with extraordinary business and civic ... receive this honor," said Rick Pierro ... any recognition, this award is a reflection of ...
(Date:5/22/2013)... Basel, Switzerland (PRWEB) May 22, 2013 ... solutions for industrial biotechnology, drug discovery, and life ... Genedata Selector ™ as its bioinformatics ... its production-relevant organisms. Genedata will provide AB Enzymes, ... manufacturers, with a hosted solution of Genedata Selector ...
Breaking Biology Technology:Cambridge Semantics Underscores Need for Smart Data during “Data Demonstration Day” on Capitol Hill 2Oligomerix, Inc. Completes Series B Financing 2Oligomerix, Inc. Completes Series B Financing 3Superior Controls of Seabrook, NH named Business of the Year for 2013 by Business NH Magazine 2AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 2AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 3AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 4
... BRISBANE, Australia and SEATTLE, Feb. 24 Implicit,Bioscience ... antibody IC14 from Eli Lilly and Company. Implicit ... to Lilly. Lilly will also,receive a royalty on ... "Implicit Bioscience brings substantial expertise and passion to ...
... Feb. 24 Nektar Therapeutics,(Nasdaq: NKTR ... fourth quarter and,year ended December 31, 2008. , ... year for Nektar," said Howard W. Robin,President and ... unique polymer,conjugation chemistry platform, we advanced numerous proprietary ...
... proteinTHOUSAND OAKS, Calif., Feb. 24 Bone Biologics, Inc. ... Aragen Bioscience, has completed development of a recombinant cell ... protein. Bone Biologics has been developing the protein as ... years of research in the lab performed by the ...
Cached Biology Technology:Implicit Licenses Clinical Stage Antibody Program From Lilly 2Implicit Licenses Clinical Stage Antibody Program From Lilly 3Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results 2Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results 3Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results 4Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results 5Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results 6Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results 7Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results 8Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results 9Bone Biologics Announces UCB-1 (NELL-1) Bone Growth Protein Production Process With Aragen Biosciences 2
(Date:5/21/2013)... to a whale entangled in fishing gear, scientists showed ... whale,s diving and swimming behavior. The monitoring revealed how ... depletes their energy as they drag gear for months ... , The scientists in this entanglement response suction-cupped a ... North Atlantic right whale called Eg 3911. The Dtag, ...
(Date:5/21/2013)... a new method for delivering molecules into single, ... surface. The technique could find applications in drug ... Bulk electroporation a technique used to deliver ... cell membrane that are caused by exposing them ... method of cell transfection. (Cell transfection is the ...
(Date:5/21/2013)... Think keeping in shape is an uphill battle? Try ... and prolonged weightlessness withers muscle and bone. , That,s ... will address with a new three-year, $1.2 million grant ... to exercise during multiyear exploratory missions. , "You could ... if you can,t get them to stick to it, ...
Breaking Biology News(10 mins):Study reveals how fishing gear can cause slow death of whales 2Study reveals how fishing gear can cause slow death of whales 3Single-cell transfection tool enables added control for biological studies 2Fueling fitness on the final frontier 2
... A novel bacterium that has been trapped more than three ... years, may hold clues as to what life forms might ... a team of scientists from Pennsylvania State University report finding ... , in the current issue of the International Journal ...
... -- Begins in Houston , , HOUSTON, June 10 ... of Houston Center for ... Technology , announce today their agreement for the ... for the U.S. Gulf Region. This Center will house all ...
... be anymore waiting in the dark at this campus bus ... group of engineering researchers at McMaster University has been installed ... The researchers are also hoping that the prototype will help ... shelter is located on the west side of University Avenue ...
Cached Biology News:A tiny frozen microbe may hold clues to extraterrestrial life 2University of Houston Site of Regional Center of Excellence 2Flexible solar strips light up campus bus shelter 2
... CyScribe GFX Purification Kit, 24 reactions. ... Cy3- and Cy5-labeled cDNA.Optimized reagents are ... and purification.Flexible and optimized protocols can ... with either Cy3- or Cy5-labeled nucleotides.Reliable ...
NORMAL DONOR DONKEY SERUM...
... 301 Power Supply, 1. 300 V, ... or constant current modes.Single-unit increments in ... reproducibility.Suitable for submarine, mini vertical, and ... as semidry and mini tank blotting ...
B3-1...
Biology Products: